Monte Rosa Therapeutics, Inc. (GLUE) is in Healthcare, Biotechnology, based in United States, listed on NasdaqGS. Market cap 880.43M USD. 52-week range 8.53 to 25.77 USD. Data as of 2026-10-09.
Monte Rosa Therapeutics, Inc., a clinical-stage biotechnology company, engages in the development of novel small molecule precision medicines that employ the body's natural mechanisms to selectively degrade therapeutically relevant proteins. The company develops orally bioavailable molecular glue degraders (MGDs), such as MRT-2359 for the treatment of MYC-driven tumors; MRT-6160 for the treatment of neurologic and systemic autoimmune and inflammatory diseases; and MRT-8102 for the treatment of ...